Your browser doesn't support javascript.
loading
Chronic hepatitis C treatment: a systematic review
Aishah Mohammed, Alenezi; Abdulaziz Hassan Mohammed, Al Fakih; Sultan Mohammed, Al Afif; Abdulkarem Mohammed, Al Afif; Bashayer Abbas, Habib; Mooj Abdullah, Alghofaili; Shaykhah Ali, Almalki; Shahad Dhafer, Adraj; Mada Khaled, Arfaj; Waad Musayid, Alsadi; Lama Hamed, Almazroei; Amjad Meshal, Allhyani; Hanof Abdulrhman, Bakri; Bandar Aedh, Alyami; Ola Ali, Alsaihati; Zahra Issa A., Al Ali; Abdulrahman Salem D., Altalhi; Abdualrhman Ali, Al Amri; Arwa Ibrahim Y., Ramel.
Egyptian Journal of Hospital Medicine [The]. 2017; 67 (1): 305-313
en Inglés | IMEMR | ID: emr-189181
ABSTRACT

Background:

Chronic hepatitis C [CHC] infection affects almost 3% of the global population and can lead to cirrhosis, liver failure, and hepatocellular carcinoma in a significant number of those infected. Thus, there is a compelling need to develop and introduce new therapeutics with a direct-acting antiviral effect in order to target various stages of the HCV lifecycle for HCV eradication without concomitant interferon
Asunto(s)
Buscar en Google
Imprimir
XML
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Ribavirina / Interferones / Hepacivirus / Simeprevir / Sofosbuvir / Genotipo Tipo de estudio: Revisiones Sistemáticas Evaluadas Límite: Humanos Idioma: Inglés Revista: Egypt. J. Hosp. Med. Año: 2017

Similares

MEDLINE
LILACS
LIS
Buscar en Google
Imprimir
XML
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Ribavirina / Interferones / Hepacivirus / Simeprevir / Sofosbuvir / Genotipo Tipo de estudio: Revisiones Sistemáticas Evaluadas Límite: Humanos Idioma: Inglés Revista: Egypt. J. Hosp. Med. Año: 2017